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Abstract
Background: Most patients with cystic fibrosis (CF) require a higher energy and protein intake than their healthy peer group.
There are few data on dietary intakes of adult patients. The aim of this study was to determine nutritional intakes in an adult
population with CF. The impact of nutritional intervention and disease on macronutrient intake was examined. Methods:
Retrospective cross-sectional analysis of 94 unweighed food diaries at annual review (1995–2000). Energy and protein intakes
were compared to the estimated average requirement (EAR) for energy and reference nutrient intake (RNI) for protein. The
effect of diet alone, oral supplements, enteral tube feeding, and cystic fibrosis related diabetes (CFRD), on macronutrient intake
was examined and impact of pancreatic sufficency (PS) and lung transplantation. Results: Mean energy and protein intakes
approached recommended CF guidelines, but in 72% of assessments these values were not achieved. Mean energy and protein
intakes for patients on diet alone and protein intake for those with CFRD failed to meet recommendations. Oral supplementation
and enteral tube feeding regimens increased energy and protein intake above recommended levels. No group achieved 40% total
energy from fat. Patients receiving enteral tube feeds had the highest mean energy and protein intakes but lowest body mass
index (BMI) and lung function. Conclusion: Adequate mean energy and protein intakes in adult patients with CF mask subgroups
of patients who fail to meet recommendations ie. diet alone, diabetic. Oral supplementation and enteral tube feeding increase
energy and protein intake but fail to achieve an adequate BMI level in subjects with a decreased clinical status. Individual
nutritional assessment remains essential.
 2003 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
Keywords: Cystic fibrosis; Adult population; Nutritional intake
1. Introduction
The median age of survival with cystic fibrosis (CF)
is now approximately 30 years w1x. Advances in dietary
management with an emphasis on higher fat diets and
the use of acid resistant pancreatic enzyme replacement
therapy (PERT) has been important in contributing to
better health, quality of life and longevity w2,3x.
Most patients with CF have higher energy require-
ments than healthy individuals of the same age due to
increased losses from fat malabsorption w4x, increased
demands imposed by infection and inflammation w5x
and a reduction in dietary intake especially during
episodes of infection. The adaptive response to malnu-
*Corresponding author..
trition in CF lung disease may also be abnormal and a
marked increase in muscle protein catabolism of patients
with CF when compared to healthy controls has been
shown w6x. The energy requirements of undernourished
adolescents and young adults with cystic fibrosis are
25–80% higher than healthy individuals of the same
age and size w7x. Nutritional guidelines, therefore rec-
ommend an intake for individuals with CF of 120–
150% of the estimated average requirement (EAR) for
energy and 200% of the reference nutrient intake (RNI)
for protein w8,9x. The dietary aim is to encourage a diet
high in fat (40% of total calories) and to maintain this
even with disease progression. Studies in children indi-
cate that the above can be difficult to achieve w10–12x.
Richardson et al. (2000) w13x have reported the nutri-
tional intake of an Australian adult population although
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Table 1
Subject characteristics at assessment
Assess Mean age Mean BMI Mean FEV1 Mean FVC
(n) (years) (kgym )2 (%) (%)
Total* 80 23.8"6.4 20.8"2.6 58.7"23.9 75.3"24.2
Diet alone 27(34%) 22.0"5.0 21.2"2.6 65.5"24.6 82.1"24.8
Oral supps 14(17%) 21.0"3.3 21.1"2.3 66.2"21.0 86.7"21.6
Enteral feed 10(12%) 21.1"3.3 18.5"1.9 37.9"13.4 52.4"13.3
Diabetic 29(36%) 27.8"7.5 21.1"2.8 55.3"23.5 70.7"22.2
BMI, Body mass index; FEV1, Forced expiratory volume in 1 s; FVC, Forced vital capacity.
PS, post-transplant excluded.*
there are little other data on the nutritional intake of
adults.
The aim of this study was to determine whether
dietary intakes in an adult population attending a region-
al cystic fibrosis unit meet current recommended guide-
lines and whether defined aspects of nutritional
intervention and disease influence energy and macro-
nutrient intake.
2. Patients and methods
This retrospective cross-sectional study examined 94
dietary assessments (48 male) completed as part of the
annual review at a time of clinical stability during the
period 1995–2000. Height and weight were recorded on
the day of assessment and BMI (weightyheight m )2
calculated.
Pulmonary function was assessed by means of stan-
dard spirometry using a Vitalograph Compact II Spirom-
eter (Vitalograph Ltd, UK). Individuals were required
to perform 1–3 satisfactory efforts and the best meas-
urements were recorded. ‘Satisfactory’ was defined as
FEV lying within 5% of last recorded respiratory1
function or repeated respiratory function on the same
day. Forced expiratory volume in 1 s (FEV ) and forced1
vital capacity (FVC) were compared with reference
values and reported as the percentage of the predicted
normal value.
At each assessment the presence of diabetes, PS and
transplant status was recorded. Length of time post-
transplant was noted. A diagnosis of diabetes mellitus
was based on the need for insulin therapy or oral
hypoglycaemic agents (pre 1995) or a positive glucose
tolerance test with a clinical need for insulin therapy
from 1995 onwards. Pancreatic insufficiency was
defined as the presence of malabsorption requiring
pancreatic enzyme replacement therapy (PERT). All
patients routinely received advice on maximising dietary
energy, protein and fat intake irrespective of BMI. Post-
transplant patients received dietetic review a minimum
of twice yearly, PS patients a minimum of 4 timesyyear
and remaining patients a minimum of 6 timesyyear.
Each patient received instruction from one of two
specialist dietitians on completing a 4 day un-weighed
dietary food record inclusive of one weekend day. All
food, drink, nutritional supplements enteral feeds and
PERT were recorded. Date of initiation of enteral feed-
ing was noted. Food records were analysed by the same
specialist dietitians using Microdiet Computer software
(University of Salford, UK, 1983–1995) to establish
energy and macronutrient intakes. Energy and protein
intakes were compared to the EAR for energy and RNI
for protein w14x. Percentage energy contribution from
protein, fat, carbohydrate and alcohol was calculated for
each assessment.
Of the total number of assessments (ns94), those
classified as pancreatic sufficient (ns6) and post-trans-
plant (ns8) were excluded and analysed separately.
The remaining assessments (ns80) were divided
according to the consumption of diet alone, dietary
supplements, enteral tube feeding, or the presence of
CFRD, in order to determine any differences in energy
and macronutrient intakes between these subgroups. The
contribution of oral supplements and enteral feeds to
total energy and protein intakes in these patient groups
was calculated. Weight, BMI and dietary intake in
different age categories was examined, excluding PS
and post-transplant patients to avoid bias. PS and post-
transplant groups were analysed separately for energy
and macronutrient intake.
Results are expressed as mean values with the range
or standard deviation. For comparison between groups
two-tailed unpaired t tests were used. The Spearman
rank linear correlation coefficient was calculated to
describe the interrelations between two measurements.
A P value of -0.05 was regarded as significant.
3. Results
3.1. Subject characteristics
Patient characteristics at assessment are detailed in
Table 1. BMI was 21.2, 21.2, 18.5, 21.1 in patients on
diet alone, oral supplements, enteral tube feeding and
diabetic, respectively. Corresponding % predicted FEV1
was 65.5, 66.2, 37.9 and 55.3%.
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Fig. 1. Relationship between dietary energy and protein intake (ns80).
Fig. 2. Mean energy intake (% EAR).
3.2. Energy and protein intakes
Mean energy intake (117% EAR) and mean protein
intake (197% RNI) were close to recommended guide-
lines. There was a significant correlation between energy
and protein intake (rs0.8, P-0.01) (Fig. 1). Although
mean intakes were close to recommended levels, only
40% of all assessments achieved an energy intake of
120% EAR, 38% a protein intake of 200% RNI and
only 28% achieved both objectives. In 21 (26%) assess-
ments patients had a BMI -19 kgym . Comparison of2
BMI and energy intake showed that 12(15%) had a
BMI-19 kgym and energy intake-120%. In 6(7.5%)2
assessments, patients had a BMI-19 kgym and energy2
intake -100% EAR.
Differences in mean energy and protein intakes for
defined patient groups are shown in Figs. 2 and 3. These
show a stepwise increase in energy and protein intake
from those on diet alone to supplements to enteral tube
feeding. With each nutritional intervention an increase
in energy and protein intake was seen with respective
figures of 100%, 126% (P-0.01) and 140% (NS) EAR
for energy and 165, 221% (P-0.01) and 248% (NS)
RNI for protein.
Diabetic assessments achieved a mean energy intake
of 120% EAR energy and 197% RNI protein and almost
achieved recommended intakes. Minimum current guide-
lines were achieved by the supplement group and enteral
tube feed groups only.
3.3. Macronutrients
The recommended percentage dietary intake from fat
is 40%. This was not achieved by either the group as a
whole or by any patient subgroup (Table 2). The highest
percentage fat intake was achieved by those on enteral
feeds (38.7%) and the lowest by those who were
diabetic or on diet alone (34.8%). Alcohol intake was
low in all groups (Table 2) but decreased as patients
progressed from diet alone to supplements and then to
enteral feeding.
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Fig. 3. Mean protein intake (% RNI).
Table 2
Macronutrient intake in adult patients with cystic fibrosis
Patient group % Fat % CHO % Prot % Alc
Total 35.7"6.2 47.9"6.2 15.2"3.4 1.6"3.3
Diet alone 34.8"7.2 48.4"7.7 14.9"3.3 2.6"4.6
Supplements 36.0"4.9 47.2"6.1 15.0"3.5 1.8"2.9
Enteral feed 38.7"2.2 45.6"3.6 15.5"2.1 0.02"0.06
Diabetic 34.8"6.6 48.4"5.6 15.6"3.9 1.0"2.1
Table 3
Change in weight, BMI and dietary intake with age
Age Assess Wt BMI % EAR energy % RNI protein % E fat
(years) (n) (kg) (wtykg )2
15–19 29 53.6"7.3 19.9"2.0 111.6"385 192.5"78.1 36.1"4.5
20–24 25 60.9"11.5 21.3"3.1 127.6"40.4 212.7"73.4 35.9"6.1
25–29 14 60.4"9.9 21.7"2.1 111.4"39.2 177.0"51.3 33.3"8.1
30–34 5 55.4"6.4 19.9"1.2 113.6"35.7 211.4"62.1 36.0"11.5
35–39 5 60.8"17.0 21.6"4.5 116.2"28.7 191.0"52.0 34.0"3.9
40–50 2 62.3"17.9 22.5"4.6 106.0"30.0 181.5"44.5 38.4"3.4
Oral supplement use and enteral tube feeds: Oral
supplements were used in 17.5% of assessments and
enteral feeds in 12.5%. Contribution of oral supplements
to overall energy intake was 17.3% and to protein intake
11.4%. Supplements were more commonly used in
males than females (71% vs. 29%). It was noted that
the younger age groups derived a higher percentage of
their nutrient intake from oral supplements. Individuals
taking oral supplements had a similar BMI and lung
function to those on diet alone.
The median length of time that patients were enterally
fed prior to assessment was 3.1 years. Enteral feeders
relied heavily on tube feeds to maintain their high
nutritional intakes of 140% EAR energy and 248% RNI
protein. These provided 50.6% of total energy and 51.1%
of protein intakes.
3.4. CFRD
Patients with CFRD were significantly older (P-
0.001) than non-diabetics and had reduced lung function
although this did not reach significance. Diabetic
patients met recommended energy guidelines but not
protein guidelines (Fig. 3) or % energy from fat (Table
3).
3.5. Age
The data were examined to see if there was any effect
of age on dietary intake (Table 3). Mean values of
energy intake were higher in each age category until
age 24. Those aged 20–24 also had the highest protein
intake. BMI levels increased in the age categories 15–
29, decreased at age 30–34 and increased again in the
age categories 35–50. The two individuals in the age
category 40–50 had the highest BMI but lowest energy
intake of any group.
3.6. PS and post-transplant
Patients with PS had the greatest lung function and
BMI of any group despite a low energy intake (104%
EAR) and protein intake (175.8%) compared to guide-
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Table 4
Demographic and nutritional data for pancreatic sufficient and post-
transplant patients with cystic fibrosis.
PS (ns6) Post-transplant (ns8)
Mean age (years) 28.0"3.9 29.9"7.8
Mean BMI (kgym )2 25.1"2.8 21.0"4.2
Mean FEV (%)1 85.7"14.4 68.1"32.3
Mean FVC (%) 99"13.2 82.4"26.1
% EAR energy 104.2"31 94.8"17.9
% RNI protein 175.8"26.6 157.1"29.5
% energy fat 36.3"4.0 38.0"4.1
lines (Table 4). Post-transplant patients were the oldest
group of patients within the study and had an adequate
BMI despite the lowest mean energy intake (94.8%
EAR). Mean length of time post-transplant was 4.7
years. There was a strong correlation between BMI and
FEV (rs0.64, P-0.001) in this group.1
4. Discussion
Several studies have examined nutritional intake in
younger or mixed age populations of people with CF
w10,12,15,16x but there are little published data on the
nutritional intakes of adults over 16 years, or whether
nutritional guidelines are met or are influenced by
changes in nutritional intervention and clinical aspects
of the disease.
Mean energy and protein intakes achieved were close
to recommended guidelines but less than the reported
energy intake in an Australian population of adult
patients with CF w13x. The mean of the group hides a
large proportion who lie below recommended levels, i.e.
60% failed to achieve recommended energy intakes,
62% failed to achieve recommended protein intake and
72% failed to achieve both. This emphasises the need
for individual dietetic assessment and care for all
patients. A high fat diet ()40% total energy from fat)
is an essential component of a high-energy intake.
Groups with the lowest fat intake were those on diet
alone who failed to meet energy and protein guidelines
and diabetic patients who failed to meet recommended
guidelines for protein. However, those consuming diet
alone also demonstrated the highest mean BMI, FEV1
and FVC% predicted of any patient (PS and post-
transplant excluded)). Adequate nutritional status (BMI
21.2 kgym ) despite lower than recommended intakes2
indicates that current guidelines are inappropriately high
for this comparatively well subgroup of the clinic
population.
CFRD is associated with clinical deterioration w17–
19x and may precede overt diabetes by up to 4 years.
Emphasis on a high fat diet, with no restriction of
refined carbohydrate, is thought to be important in
achieving the higher energy intakes required in this more
compromised group. This conflicts with dietary infor-
mation given to the non-CF diabetic population where
a diet low in refined carbohydrate, low in fat and high
in fibre is advised. Patients with CFRD achieved rec-
ommended guidelines for energy but not % energy from
fat. The higher % energy contribution from carbohydrate
of the CFRD diet (48.4%) was closer to guidelines for
the general diabetic population w20x and those on diet
alone. Further studies are required to establish whether
recommended changes in dietary intake occur at diag-
nosis or over time.
Work has shown that dietary intake may become
compromised in CFRD because of problems concerning
food and eating behaviour w21x. A consistency of
approach and nutritional targeting is, therefore needed
in this more vulnerable group of patients.
The use of oral supplements is the first line treatment
when dietary counselling alone fails. In adolescents their
use is associated with a significant increase in energy
intake, but without any corresponding improvement in
nutritional indices w16x. Approximately one-fifth of the
assessments in this study included oral supplements that
resulted in significant increases in energy and protein
intake. Similar improvements in energy intake have
previously been reported w16x. Oral supplements provid-
ed 17.3% of the total energy and 11.4% of the total
protein intake. The greatest use of oral supplements was
in the younger age groups 15–19 years (31%) and 20–
24 years (40%). The gradual reduction in use thereafter
may be due to a combination of taste fatigue, progression
to enteral feeding and survival of milder genotypes
requiring less intensive nutritional therapy.
Despite the highest mean energy and protein intakes
and the highest percentage energy intake from fat,
enteral tube feeders had the poorest lung function and
BMI of any group within the study. Bell et al. (1998)
w22x reported a similar trend in an adult Welsh popula-
tion. The enteral tube feeds provided half of the energy
and protein intake for these patients, although the choice
of formulae contributed to the higher energy and protein
intakes observed (patients routinely received a 2 kcaly
ml high fat feed). There is a need for longitudinal data
to show the effects of enteral tube feeding on nutritional
status and lung function.
As severity of lung disease and nutritional status are
related, nutritional status might be expected to decline
with age. Nir et al. (1996) w3x examined long term
survival and nutritional data in a Danish population and
showed that weight and BMI progressively decreased in
patients)15 years. None of their patients were enterally
tube fed. In this study, mean weight was initially seen
to increase as young, sicker individuals died and then
decreased around the median age of survival. A further
increase in weight and BMI was then observed in the
older group of patients (aged 35 and over). This suggests
that age and preservation of nutritional status are possi-
bly related to a milder disease phenotype. Inclusion of
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such data in future studies may provide valuable addi-
tional information on dietary requirements.
Further limitations concern the collection of data in
the study. Food diaries were obtained from patients
attending for annual assessment and can be time con-
suming to record. The patient’s willingness to complete
and return the food diary could obviously introduce a
bias in favour of more compliant or motivated individ-
uals. Nonetheless the completed assessments were pro-
portionally representative of the clinic population in
terms of the percentage of patients consuming diet alone,
oral supplements and enteral feed w23x.
The unique characteristics of PS and post-transplant
patients were evident in their nutritional status and
dietary intake. Those with PS had a mean BMI lying
above the desired BMI range of 19–25 for members of
the general UK population. Lack of malabsorption and
comparitively good lung function will potentially lower
requirements in this patient group. The low energy intake
(104% EAR) in PS patients indicates that their energy
requirements are closer to that of the non-CF population.
The requirements of CF individuals post-transplant are
also unclear. Madill et al. (1993) w24x were able to
improve nutritional status post-transplant with signifi-
cantly decreased caloric intake. Our own data did not
allow us to observe changes over time but demonstrates
that an adequate BMI can be achieved post-transplant
with a relatively low energy intake. Further work is
needed to establish energy requirements and longitudinal
changes in these groups.
5. Conclusion
In conclusion, we have shown that mean energy and
protein intakes in an adult population are close to
recommended guidelines, although fat recommendations
are not met. Adequate mean energy and protein intakes
mask the fact that -40% of patients achieve the
recommended intake for energy or protein and only
28% achieve both. The mean hides an important under-
nourished group of patients (15%) who had a BMI-19
kgym and energy intake of -120% EAR.2
Particular subgroups do not achieve recommended
levels, i.e. those on diet alone who may have lower
requirements and those with CFRD who appear to need
greater dietary intervention and monitoring, although
the latter group only just fell short of recommended
levels. The Introduction of oral supplements and enteral
tube feeds results in increased energy and protein intake.
Despite this, patients with a high macronutrient intake
have low BMI levels, suggesting that subjects with a
worse clinical status may have significantly higher
nutrient needs. PS and post-transplant patients have a
good clinical status and adequate BMI despite low
energy intakes.
We recommend that dietary assessment is essential to
identify the need for earlier nutritional intervention. The
issue of how oral supplementation and enteral feeding
can best meet additional energy requirements must be
addressed. Diabetics, those on diet alone, PS and post-
transplant patients must not be assessed by the mean of
their population but by individual assessment. This must
be annual with trusts funding adequate dietetic support
and patients convinced of the need for complete
assessment.
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